News & Events
June 18, 2016
Critical Path for Parkinson’s (CPP) members met on June 18th in Berlin for the First Annual Consortium Member MeetingCritical Path for Parkinson’s (CPP) members met on June 18th in Berlin for the First Annual Consortium Member Meeting. A group of 34 world leading experts from industry, academia and patient advocacy organizations convened for a day to discuss the progress to date and the future scope of the multinational consortium. Themes included recognition of...
May 26, 2016 - July 14, 2016
Current trends in BSEP inhibition and perturbation to bile acid homeostasis as mechanisms of drug-induced liver injuryThe Critical Path Institute’s Predictive Safety Testing Consortium hosted a webinar series focused on BSEP inhibition and perturbation to bile acid homeostasis as mechanisms of drug-induced liver injury. Over the course of six two-hour webinars, scientists presented current data and research on clinical examples of BSEP inhibition and hepatotoxicity, in vivo tools for confirming perturbation...
May 1, 2016
Pediatric Academic Societies Meeting State of the Art PlenaryMay 1, 2016 3:30 PM – 5:30 PM Baltimore Convention Center Baltimore, Maryland Session Details: Global Efforts to Accelerate Neonatal Drug Development Session Number: 2665 PAS State of the Art Plenary Baltimore Convention Center ~ 337/338 Neonatologists and scientists interested in the pharmacology, pathophysiology, genetics, and treatment options for commonly encountered neonatal conditions. Chairs: Christine...
April 27, 2016 - April 28, 2016
Seventh Annual Patient-Reported Outcome Consortium WorkshopPartners in Progress: Sharing the Vision, Shaping the Future April 27 – 28, 2016 Sheraton Silver Spring Hotel 8777 Georgia Avenue Silver Spring, MD 20910 On April 27-28, 2016 the SEVENTH ANNUAL PATIENT-REPORTED OUTCOME CONSORTIUM WORKSHOP was held in Silver Spring, Maryland. The overall Workshop objectives were to: • Provide updates on FDA’s Clinical Outcome Assessment...
April 26, 2016
Workshop on Clinical Outcome Assessments (COAs) in Cancer Clinical TrialsApril 26, 2016 Sheraton Silver Spring Hotel 8777 Georgia Avenue Silver Spring, MD 20910 The Workshop on Clinical Outcome Assessments in Cancer Clinical Trials, was co-sponsored by the FDA’s Office of Hematology and Oncology Products and the Critical Path Institute’s Patient-Reported Outcome (PRO) Consortium. The workshop aimed to provide a forum for collaborative and productive...